#LCSM Chat Topic 10/23: How can we help new stage IV #lungcancer patients consider 2nd opinions, mutation testing and clinical trials?

Most patients experience a period of stunned disbelief or shock when they hear a diagnosis of “metastatic lung cancer.”  For those who are offered treatment options, the first few months revolve around medical appointments.  Others may only be told to go home and get their affairs in order.  Patients and family members may be in denial, or trying to process what all those dismal survival statistics mean for their future. It might be the first time the patient or a family member has had to confront the possibility of death for themselves… Read More

Chat Topic 8/14: How Can We Bring the Benefits of #LCSM to Those Who Are Not Online?

Our 8/14 #LCSM Chat (at 8 PM ET, 5 PM PT) will explore how best to bring the benefits of the online lung cancer community to those who are not on the Internet.  What aspect of #LCSM would benefit them most, and what would be the best way to reach them?  Our moderator Dr. Jack West will raise the following questions for discussion: T1: What benefits of the #LCSM community would be most useful to those affected by lung cancer who are not online? T2: How might we extend the #LCSM community… Read More

#LCSM Chat 5/22 Preview: Top 10 Key LC Presentations at ASCO 2014

By Howard (Jack) West, MD Please join us for the next #LCSM chat on Thursday, May 22, 2014, at 8 PM ET (5 PM Pacific). Our topic will be “Top 10 Key LC Presentations at ASCO 2014.” I’ll be moderating. Every year, many of the key developments in cancer care are presented at the annual American Society of Clinical Oncology (ASCO) meeting in Chicago at the end of May. This year ASCO will highlight several practice-changing results for lung cancer. Impressively, the most important trials this year focus on treating a broad… Read More